Your browser doesn't support javascript.
loading
Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.
Johansson, Patricia; Laguna, Teresa; Ossowski, Julio; Pancaldi, Vera; Brauser, Martina; Dührsen, Ulrich; Keuneke, Lara; Queiros, Ana; Richter, Julia; Martín-Subero, José I; Siebert, Reiner; Schlegelberger, Brigitte; Küppers, Ralf; Dürig, Jan; Murga Penas, Eva M; Carillo-de Santa Pau, Enrique; Bergmann, Anke K.
Afiliación
  • Johansson P; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany. patricia.johansson@uk-essen.de.
  • Laguna T; Computational Biology Group, Precision Nutrition and Cancer Research Program, IMDEA Food Institute, 28049, Madrid, Spain. teresa.laguna@imdea.org.
  • Ossowski J; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Pancaldi V; Institute of Human Genetics, Medical School Hannover (MHH), Hannover, Germany.
  • Brauser M; Centre de Recherches en Cancérologie de Toulouse (CRCT), Université de Toulouse, CNRS, Université Toulouse III-Paul Sabatier, Centre de Recherches en Cancérologie de Toulouse, INSERM U1037, 31037, Toulouse, France.
  • Dührsen U; Barcelona Supercomputing Center, 08034, Barcelona, Spain.
  • Keuneke L; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany.
  • Queiros A; Department of Hematology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Richter J; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Martín-Subero JI; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, 08036, Barcelona, Spain.
  • Siebert R; Institute for Pathology, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Schlegelberger B; Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), University of Barcelona, 08036, Barcelona, Spain.
  • Küppers R; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010, Barcelona, Spain.
  • Dürig J; Institute for Human Genetics, Christian-Albrechts-University Kiel and University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany.
  • Murga Penas EM; Institute of Human Genetics, University of Ulm and University Medical Center Ulm, Ulm, Germany.
  • Carillo-de Santa Pau E; Institute of Human Genetics, Medical School Hannover (MHH), Hannover, Germany.
  • Bergmann AK; Faculty of Medicine, Institute of Cell Biology (Cancer Research), University of Duisburg-Essen, Virchowstr. 177, 45122, Essen, Germany.
Clin Epigenetics ; 14(1): 148, 2022 11 14.
Article en En | MEDLINE | ID: mdl-36376973
ABSTRACT

BACKGROUND:

The molecular pathogenesis of T-cell large granular lymphocytic leukemia (T-LGLL), a mature T-cell leukemia arising commonly from T-cell receptor αß-positive CD8+ memory cytotoxic T cells, is only partly understood. The role of deregulated methylation in T-LGLL is not well known. We analyzed the epigenetic profile of T-LGLL cells of 11 patients compared to their normal counterparts by array-based DNA methylation profiling. For identification of molecular events driving the pathogenesis of T-LGLL, we compared the differentially methylated loci between the T-LGLL cases and normal T cells with chromatin segmentation data of benign T cells from the BLUEPRINT project. Moreover, we analyzed gene expression data of T-LGLL and benign T cells and validated the results by pyrosequencing in an extended cohort of 17 patients, including five patients with sequential samples.

RESULTS:

We identified dysregulation of DNA methylation associated with altered gene expression in T-LGLL. Since T-LGLL is a rare disease, the samples size is low. But as confirmed for each sample, hypermethylation of T-LGLL cells at various CpG sites located at enhancer regions is a hallmark of this disease. The interaction of BLC11B and C14orf64 as suggested by in silico data analysis could provide a novel pathogenetic mechanism that needs further experimental investigation.

CONCLUSIONS:

DNA methylation is altered in T-LGLL cells compared to benign T cells. In particular, BCL11B is highly significant differentially methylated in T-LGLL cells. Although our results have to be validated in a larger patient cohort, BCL11B could be considered as a potential biomarker for this leukemia. In addition, altered gene expression and hypermethylation of enhancer regions could serve as potential mechanisms for treatment of this disease. Gene interactions of dysregulated genes, like BLC11B and C14orf64, may play an important role in pathogenic mechanisms and should be further analyzed.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Granular Grande Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Granular Grande Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article